Brivo Systems, leader in Software as a Service (SaaS) applications for security management, announced Amneal Pharmaceuticals has installed Brivo ACS WebService at four company locations, covering 125 doors, and managing nearly 1,000 employees and contractors.
Brivo Systems, leader in Software as a Service (SaaS) applications for security management, announced Amneal Pharmaceuticals has installed Brivo solution at four company locations, covering 125 doors, and managing nearly 1,000 employees and contractors.
Amneal Pharmaceuticals, a U.S.-based firm that develops, manufactures and distributes generic pharmaceuticals regulated and approved by the U.S. FDA. Known as “Generic's New Generation,” the company utilizes its newly expanded R&D and manufacturing capabilities to conceive breakthrough developments with lasting impact for a robust product pipeline.
“We are in the narcotics manufacturing business; security is top priority,” explained Rob Symbouras, DEA Compliance Manager and Security Manager. “We are very security minded, and we have access control and CCTV installed on top of our burglar alarm systems extensively throughout our manufacturing plants, warehouse, vaults, perimeters, and offices. Our security systems help ensure we comply with strict FDA guidelines to ensure Good Manufacturing Practices, avoid product cross contamination, and guard against sabotage and employee theft.”
Amneal began installing Brivo in 2006 and, at present, the company uses Brivo solutionto manage approximately 125 doors at four facilities, with the focus on its manufacturing plants. Symbouras continued, “We have to prevent unauthorized personnel from entering manufacturing rooms as well as limit access to the specific areas of the facility based on an employee's job description. For the vaults, where controlled substances are stored, Amneal employs three layers of security—alarm codes, access control, and requiring two people to simultaneously provide both halves of the necessary access information.”